Learn why the FDA is asking to update testosterone replacement therapy labels after a major review of new evidence.

The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits.

Second, the changes would ease longstanding warnings about the use of the hormone therapy in those with prostate cancer. Current labels say testosterone should not be used in men ...

Q. My doctor prescribed testosterone four years ago, and my hormone levels are now normal. I know that there were concerns about heart problems, but my blood pressure (BP) is 115/76, pulse is 70, and ...

Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...

Most men assume that if their testosterone is low, they can get treatment. But since 2015, FDA labeling has included cautionary language noting that the safety and effectiveness of testosterone ...

Signs and symptoms of low testosterone are often very generalizable and can be due to something else, either in addition to ...

Getting testosterone therapy without the right medical care is a growing problem. Here's how to know if you need TRT, and ...

Experts explain why the hormone may be a meaningful signal for men’s overall health.

The use of metformin and testosterone replacement therapy, either individually or in combination, is associated with significant reductions in the incidence of prostate and colorectal cancer in men ...